Advarra
Advarra, headquartered in Columbia, Maryland, supports over 3,500 institutions and 50,000 investigators with comprehensive clinical research services and technology solutions.
Company Headquarters
Advarra is headquartered in Columbia, Maryland. This strategic location allows the company to maintain close proximity to various research institutions and healthcare facilities, supporting its large base of clients and partners.
Services
Advarra offers a wide-ranging suite of services including Institutional Review Board (IRB), Institutional Biosafety Committee (IBC), Data Monitoring Committee (DMC), and Endpoint Adjudication Committee (EAC) services. Additionally, the company provides consulting in GxP, research compliance, and site operations, alongside professional services like coverage analysis, budget negotiation, and technology staffing. Their training solutions include clinical research site training, research-ready training, and custom eLearning.
Technology Solutions
Advarra’s technology solutions are widely adopted, with more than 50,000 investigators leveraging their platforms. Notably, 78% of NCI-designated Cancer Centers use Advarra technology. Key products include the Longboat platform, which centralizes and simplifies clinical trials, and the eRegulatory Management System, which improved regulatory efficiency by 20% at Inova Health System. The Insights platform has also enhanced data analytics and visualization capabilities at the University of Wisconsin Carbone Cancer Center.
Clientele and Usage
Advarra supports over 3,500 institutions, hospitals, health systems, and academic medical centers. Each year, the company oversees more than 12,000 open protocols, providing extensive support in clinical research. The IRB of record service was notably utilized for the phase I trial of the first-in-human dose-escalation study of an mRNA Vaccine Against SARS-CoV-2. Additionally, Advarra's IRB and IBC reviews and Gene Therapy Ready site network have helped reduce study startup timelines for IQVIA.
Clinical Research Network
Advarra has established a Clinical Research Network that integrates sites, sponsors, and CROs to improve patient centricity and expedite the market introduction of new treatments. This network aims to streamline processes and foster collaboration within the clinical research ecosystem, enhancing the overall effectiveness and efficiency of clinical trials.
DE&I Initiatives
Advarra's Diversity, Equity, and Inclusion (DE&I) Committee is dedicated to enhancing cultural competence, promoting equity efforts, and fostering an inclusive culture within the company and its research activities. The initiatives include addressing underrepresented populations in clinical trials and collaborating with thought leaders to tackle significant DE&I issues in clinical research.